Related Articles
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profile
The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats
Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis
iTRAQ‑based quantitative proteomics analysis of the hepatoprotective effect of melatonin on ANIT‑induced cholestasis in rats
Identification of potential biomarkers in cholestasis and the therapeutic effect of melatonin by metabolomics, multivariate data and pathway analyses